On June 8, 2026, the U.S. Department of Defense updated its so-called "Chinese Military Company List" (CMC List) under Section 1260H of the National Defense Authorization Act, adding 188 Chinese entities including Wuxi AppTec, Alibaba, Baidu, BYD, and Unitree Robotics. The expansion’s speed and coverage are unprecedented — spanning from traditional defense industries to biotechnology, from internet platforms to new-energy vehicles, encompassing virtually every Chinese industrial sector with global competitiveness.
This time, however, the response was qualitatively different. Wuxi AppTec led the charge by filing a formal lawsuit against the U.S. Department of Defense in the U.S. District Court for the District of Columbia, directly challenging the CMC designation as "lacking factual basis and unsupported by legal standards." BYD, Alibaba, and Baidu quickly followed, issuing collective statements pledging to pursue all available legal remedies.
Wuxi AppTec's lawsuit is not a simple act of legal self-defense — it is a carefully calculated game played within the rules. Chinese companies are learning to use their opponent's judicial system to counter the politicization of administrative power, taking the Pentagon's unilateral discretion before the court of judicial review. Economist Zhang Jie's analysis reveals a variable often overlooked: the U.S. judiciary's power to constrain the executive branch may be precisely the opening this round of counterattacks is designed to exploit.
Why This Time is Different
Since the CMC List was introduced, over 800 Chinese entities have been designated — and never before has there been a legal counterattack of this scale. The change operates on three levels:
First, reversal of the burden of proof. The Pentagon's CMC designation process lacks transparent standards — no public evidence is required, no administrative hearing, no factual substantiation. Wuxi AppTec's lawsuit directly challenges the absence of procedural due process. If the court accepts the case and proceeds to substantive review, the DoD will be compelled to disclose the basis and criteria for its designations.
Second, an escalation in the nature of the challenge. This is not an administrative appeal or a diplomatic protest — it is a federal lawsuit. It means the Pentagon will be forced to mount a legal defense and submit to jury scrutiny of evidence in the judicial process. As Zhang Jie notes: "Every time the U.S. government is sued, it has to respond to a jury's interrogation — and that may make them less arbitrary in their decision-making."
Third, a qualitative shift in tempo. Moving from "passive acceptance" to "active counterattack," Chinese enterprises have come to recognize that resistance within the rules-based system is far more effective than protest outside it.
The Gap in Judicial Independence
Zhang Jie's deep analysis touches a central paradox: in the country most enamored with "securitization," its judicial system may be the most effective tool for correcting that very deviation.
The U.S. Supreme Court's ruling that struck down President Trump's unilateral global tariffs as unconstitutional serves as a vivid precedent. "To many Chinese, this result seemed surprising," Zhang writes, "but to Americans it was not unexpected — because their judicial system is independent of the executive branch."
This means: when the executive branch's list-making goes too far beyond the rule of law, the courts have the capacity to pull it back — not out of sympathy for China, but because the judicial system has its own internal logic of preserving procedural due process.
The Space for Rule-Bound Contestation
At a deeper level, Zhang's analysis touches a soft spot in America's national narrative. As an immigrant nation, America's global appeal rests on its claimed institutional superiority — the so-called "shining city on a hill." Sustaining this narrative forces the United States to act "within a legal framework while occupying the moral high ground" in its public operations.
"To destroy this," Zhang argues, "would shake the foundations of the American state itself."
In other words, the U.S. cannot openly admit that its list is a political manipulation. This creates a space for strategic contestation: when Chinese companies move the dispute from the administrative arena to the courtroom, the U.S. government must respond in the language of the law, rather than glossing things over in the name of national security.
Wuxi AppTec's litigation strategy does not depend on "winning" as its sole objective. Even if it loses, the legal battle itself has already produced substantive effects — it forces the Pentagon to publicly defend its evidentiary standards and legal reasoning behind list designations, objectively compressing future room for arbitrary expansion. If it wins, the resulting precedent will impose binding constraints.
Broader Industrial Signal
Wuxi AppTec is only the beginning. Each of the 188 listed entities faces a similar choice: accept or fight back?
Based on public statements so far, virtually all the leading Chinese companies on the list have chosen "legal remedies." This is no coincidence. It reflects a collective learning process within Chinese industry — moving from "passive response" to "active governance" in the arena of rules-based competition.
Alibaba Takes the Baton — The 1260H Rules-Based Contestation Spreads from Wuxi AppTec
Less than ten days after Wuxi AppTec's lawsuit captured the spotlight, Alibaba joined the same campaign on June 25, 2026. Multiple international media outlets reported that Alibaba had formally sued the U.S. Department of Defense in the U.S. District Court for the Northern District of California in San Jose, seeking removal from the 1260H CMC List.
Similar path, different weight. Alibaba's most recent annual report disclosed US$38 billion in annual revenue — several times that of Wuxi AppTec. Its entry elevates the collective legal counteroffensive of Chinese companies to a new order of magnitude. More importantly, Alibaba's core businesses — retail, logistics, and enterprise IT — have an even weaker connection to military activities than Wuxi AppTec's biopharmaceutical work, giving it greater room for argument in court.
A procedural opening — the capriciousness of the listing process. A key detail in Alibaba's case: in February, the DoD updated the list and included Alibaba, then promptly removed it without explanation. The formal re-listing in early June constituted a second operation without disclosure of why the previous removal occurred. This pattern of "list → remove → re-list" directly undermines the DoD's argument for procedural legitimacy in its list-making process. Alibaba's legal team will almost certainly use this as key evidence to challenge the arbitrariness and non-procedural character of the designation process.
The macro-backdrop of Chinese countermeasures. On June 22, China's Ministry of Commerce placed 10 U.S. entities on an export control restricted list and restricted 46 U.S. companies from participating in government procurement; on June 25, Alibaba filed its lawsuit. These events unfold along the same timeline — China's reciprocal countermeasure framework is expanding from government action to enterprise action, forming a dual-track structure of "administrative countermeasures + legal counterattacks." Seen alongside Wuxi AppTec's earlier lawsuit, this model is proving replicable: litigation as a compliance-based counterattack tool is being incorporated into China's overall strategic toolkit.
Sputnik News interview with economist Zhang Jie · 2026-06-16
Guanchazhe (Observer Network) · 2026-06-25 14:27 — Alibaba sues U.S. DoD
Sputnik News · 2026-06-25 14:27 — Alibaba has sued the U.S. Department of Defense
The Judge's Injunction — Judicial Check Lands on the 1260H List for the First Time
On August 8, 2026, this rules-based game received its first substantive response from a court. U.S. District Judge James Boveberger blocked the Department of Defense from adding Wuxi AppTec to its list of companies deemed to support Beijing's military, ruling that the government had failed to demonstrate the reasonableness of the decision. The judge had issued the order back in June, immediately after Wuxi AppTec filed suit, to keep the designation from taking effect — the injunction itself is not new — but the reasoning is more worth reading than the injunction. The judge wrote that "a prominent sign sends a clear message: stay away," noting that since then Wuxi AppTec's customers and suppliers had canceled contracts, terminated long-term cooperation, and shifted business to competitors.
This ruling turns the "reversal of the burden of proof" predicted at the start of this page into reality. One data chain in Wuxi AppTec's court filings has been repeatedly cited by media: the company employs roughly 450 people in the United States, serves more than 1,000 American customers, the majority of its board and senior management are U.S. citizens, and American customers contributed about 70 percent of revenue last year. The lawsuit's wording is even more blunt — the designation is "arbitrary, capricious, and without factual basis," the "product of political pressure."
The game logic recorded in the opening section was that the lawsuit does not depend on "winning" as its sole objective — even a loss would force the Pentagon to defend itself publicly. This section delivers the upgraded version of that logic: when the injunction actually lands, the rules-based contest shifts from "compressing room for arbitrary expansion" to "freezing the existing designation in place." The customer structure Wuxi AppTec disclosed (American customers providing 70 percent of revenue) explains precisely why the judiciary was willing to step in: for the court, this is not a Chinese company versus the Pentagon — it is American jobs, American customers, the American supply chain versus an evidentiary-thin administrative list.
The injunction's scope also reveals the limit of this win. Under recent U.S. law, from later this month the DoD may not enter into contracts with listed companies, and from 2027 may not purchase their products or services through third parties — but being added to the list itself does not amount to formal sanctions. In other words, the injunction freezes "the chain reaction of contracts triggered by the designation taking effect," while the administrative operation of the list itself can continue, and companies can be re-listed. What Judge Boveberger did is procedural correction, not political alignment: he asks only that the DoD produce decent evidence.
Lingshi Xiantan (republished from NDTV) · 2026-08-09 05:57 — U.S. Judge Boveberger blocks the DoD from placing Wuxi AppTec on the Chinese military company list, citing insufficient evidence; Wuxi AppTec employs 450 people in the United States, serves more than 1,000 American customers, most executives are U.S. citizens, American customers contributed about 70 percent of revenue; the June order had already blocked the designation from taking effect; the blacklist expanded to 188 entities in June (including Alibaba, Baidu, BYD, NIO); from late August the DoD may not contract with listed companies, from 2027 may not make third-party purchases; Wuxi AppTec serves more than 4,000 pharmaceutical companies, market cap about US$43 billion.